Tag Archives: Technology

The Construction Industry Is Now Ripe For Development: Top 5 Trends Beyond 2018

Albany, New York, Nov 16, 2017: Market Research Hub (MRH) has added a new report titled “The construction Industry is now ripe for development: Top 5 Trends Beyond 2018. The report offer details about the current trends as well as the scope for the construction Industry in the coming forecast. The study also covers information about the development and market share based on different active regions. Furthermore, an anticipated growth is also highlighted in the report for the concerned sector which specifies a prosperous future.

Request Free Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1374877

Global Cell Based Assay Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Cell Based Assay Market

Cell based Assay are the analytical techniques to determine the different parameters such as biochemical or cellular functions of a living cell. Cell based Assay are used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay are commonly used to measure motility, toxicity, cell proliferations, enzyme activity, and morphology in the diagnostics and drug discovery. Cell based Assay are carried in several therapeutic areas such as cancer, stem cells, immunology, and others.

Blockchain Technology Industry analysis research and trends report for 2017-2024

Blockchain Technology Market size is expected to exhibit significant growth in the forecasted timeline due to the its immense benefits such as elimination of third-party authorities to securely verify and validate online transactions, enhanced transparency and immutability of online transactions, and significant reduction in error rates along with its ability to eliminate duplicative records.

A blockchain is a distributed database holding public ledger or financial records of all the transactions and digital events that have been executed among the participating entities and shared across the distributed database. A consensus of a majority of participants verifies each transaction in the ledger which can never be erased from the database. Basically, it contains a verifiable and certain entry of every transaction ever made.  As different participants track and verify such transactions, the system eliminates the need for any kind of third-party verification.

Fitness Equipment Market in APAC Country to gain substantial revenue from health club applications by 2024

Fitness Equipment Market is forecast to record a valuation over USD 14 billion by the end of 2024, with a projected CAGR of 3% over the period of 2017-2024; according to a new research report by Global Market Insights, Inc. In a bid to respond to the rising health concerns, fitness equipment market has been experiencing a strong footing especially when technology is empowering this business space. Fitness has been recognized as an integral component of well-being and longevity. With regards to this, there has been an influx of latest trends in the healthcare fraternity that are specifically designed keeping into consideration the sedentary lifestyles of the consumers.

Cloud Access Security Brokers Market by Cloud Deployment

​According to a new market report published by Transparency Market Research entitled “Cloud Access Security Brokers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” the cloud access security brokers market was worth US$ 3,371.4 Mn in 2015 and is expected to reach US$ 13,218.5 Mn by 2024, expanding at a CAGR of 16.7% from 2016 to 2024. North America was the largest market for cloud access security brokers in 2015. The growth in this region is being driven by the presence of a large number of small and medium-sized businesses (SMBs), start-ups, and large corporate enterprises.

Mobile TV Market on Cusp of Unprecedented Growth, Steered by Growing Pay TV Service Subscriptions

​The global market for mobile TV is exceedingly fragmented and the top 10 players accounted for a mere 23.3% in 2015. These companies, namely Comcast Corporation, AT&T, Inc., MobiTV, Inc., Sky plc, Bell Canada, Verizon Communications, Inc., Bharti Airtel, Consolidated Communications, Orange S.A., and Charter Communications, do, however, enjoy a strong foothold in several regional markets and have set entry-level barriers rather high.

Converged Infrastructure Market Shift toward Cloud-based Data Centers

​Transparency Market Research (TMR) notes that the leading players in the global converged infrastructure market are Dell EMC, Nutanix, Inc., and Hewlett-Packard Company. These companies are known to offer best on-premise data centers in a hybrid cloud world. In the coming years, companies are expected to look at geographical expansion through mergers and acquisitions and meaningful collaborations to increase their reach. Business expansion through investment will also be an important strategy adopted by the players in the global market.

Global Venous Thromboembolism Treatment Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Venous Thromboembolism Treatment Market
Venous thromboembolism is a malady caused by the coagulating of blood in the vein which prompts confinement of blood stream inside the circulatory framework. Venous thromboembolism is ordered into pneumonic embolism and profound vein thrombosis. Profound vein thrombosis is mostly happened because of the thickening of the blood in the profound vein (usually in the leg). The framed DVT cluster severs and streams to the lungs known as aspiratory embolism which is an extreme complexity of profound vein thrombosis (DVT). Venous thromboembolism normally happens in matured people with over 60 years. Individuals with overweight, people with thicker blood and the people experiencing immune system issue, for example, (lupus, rheumatoid joint pain and so on.) or malignancy are at higher danger of venous thromboembolism. Venous thromboembolism can cause unending confusions, for example, post-thrombotic disorder (PTS) or perpetual thromboembolic aspiratory hypertension (CTEPH). The manifestations related with the venous thromboembolism incorporate enlarged blood veins in legs and chest, oedema, fever, tachycardia, and dyspnoea. Lower limits are the most well-known site for DVT, however different areas influenced incorporate the mesenteric, furthest points, pelvic veins, and cerebral veins.
The venous thromboembolism treatment market is growing at a significant CAGR due to increase in geriatric population. Rise in the government expenditure, increase in the incidence of venous thromboembolism are fuelling the venous thromboembolism treatment market. Furthermore, increase in surgical procedures such as hip and knee replacements that are risk factors for venous thromboembolism conditions, growing patient awareness venous thromboembolism conditions expected to boost the venous thromboembolism treatment market growth over the forecast period.  However, high cost of deep vein thrombosis treatment, high unmet needs of currently available treatment procedures, and adverse effects associated with drugs hinder the growth of venous thromboembolism treatment market. Similarly, stringent regulatory approvals, the presence of alternatives treatments such as thrombectomy and percutaneous techniques are hindering the growth of venous thromboembolism treatment market over the forecast period.
A sample of this report is available upon request @
The venous thromboembolism treatment market is segmented on the basis of drug type, disease type, and distribution channel
Based on drug type, venous thromboembolism treatment market is segmented into the following:
• Factor Xa inhibitors
• Thrombolytic therapy
• Plasminogen activators
• Fondaparinux
• Dabigatran
• Warfarin
Based on disease type, the venous thromboembolism treatment market is segmented into the following:
• Deep vein thrombosis
• Pulmonary embolism
Based on distribution channel, the venous thromboembolism treatment market is segmented into the following:
• Hospital pharmacies
• Online Pharmacies
• Retail pharmacies
To view TOC of this report is available upon request @
The growth of venous thromboembolism treatment market is due to rise in prevalence of venous thromboembolism (According to the International Society on Thrombosis and Haemostasis, Inc.(ISTH), approximately 10 Mn cases of venous thromboembolism occur annually). The most commonly adopted strategies by industry players include new product launches with technological innovations, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant venous thromboembolism treatment market share. For instance, in March 2017, The Apex trial reported that extended use of betrixaban beyond the parenteral prophylaxis with enoxaparin reduces the venous thromboembolism incidence among the patients. Similarly, in May 2011, Eliquis (apixaban) approved In Europe for preventing venous thromboembolism after elective knee or hip replacement. Also, in January 2015, Bayer forms the collaboration with academic and governmental institutions for Rivaroxaban study in patients with a recent embolic stroke of undetermined source.
Geographically, venous thromboembolism treatment market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. North America anticipated to hold the largest share in the venous thromboembolism treatment market owing to increase in the incidence (According to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually) and prevalence rate, rise in demand for advanced treatments, and increase in aging population in the North America region. Moreover, rise in healthcare expenditure, growing awareness regarding the disease and treatments, and increase in prevalence rate in the Europe region drives the venous thromboembolism treatment market over the forecast period. Asia-Pacific is a key region for venous thromboembolism treatment market due to increase in the government expenditure and healthcare infrastructure. However, high cost of the venous thromboembolism treatment, and low awareness regarding venous thromboembolism treatment among key stakeholders are the key factors hindering the venous thromboembolism treatment market growth in Latin America and Middle East and Africa regions.
Some of the players in venous thromboembolism treatment market are Sanofi (France), Pfizer Inc. (U.S.), Daiichi Sankyo Co. Ltd. (Japan) , Bristol Myers Squibb (U.S.), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Merck & Co. (U.S.), Astellas Pharma Inc. (Japan), Sawai Pharmaceuticals Co. Ltd. (U.S.), Abbott Laboratories (U.S.), Wockhardt Ltd (India), Bayer AG (Germany), and Dupont  (U.S.) to name a few.
Need more information about this report @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

E SIM Card Market Asia Pacific to Exhibit Leading CAGR

​The global market for E-SIM card is envisioned to witness the entry of several new players, thereby intensifying the level of competition in the near future, observes a recent report by Transparency Market Research. Some of the leading companies in the market are Telefonica S.A., Gemalto N.V., Apple Inc., Samsung, NTT DOCOMO Inc., Sierra Wireless Inc., ST Microelectronics, Giesecke & Devrient GmbH, Deutsche Telekom AG, and OT-Morpho.

The report states that the global E SIM Card Market will exhibit an impressive CAGR of 13.5%, rising from a valuation of US$4,095.6 mn in 2016 to an opportunity of US$14,613.1 mn by 2025.

Designed by CyFocus.com
Powered by CyFocus.net